These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8859936)
1. Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats. Laycock SK; Kane KA; McMurray J; Parratt JR J Cardiovasc Pharmacol; 1996 May; 27(5):667-72. PubMed ID: 8859936 [TBL] [Abstract][Full Text] [Related]
2. [The effects of the angiotensin converting enzyme inhibitor, captopril, on catecholamine concentrations in rat plasma, heart, brain and kidneys (author's transl)]. Hirata Y; Goto A; Takeda T; Ishii M; Nishiyama K; Ikeda T; Nakamura Y; Kimura K; Yamakado M; Atarashi K; Uehara Y; Murao S Nihon Naibunpi Gakkai Zasshi; 1981 Aug; 57(8):1097-108. PubMed ID: 6274707 [TBL] [Abstract][Full Text] [Related]
3. Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats. Gallego M; Espiña L; Vegas L; Echevarria E; Iriarte MM; Casis O Pharmacol Res; 2001 Oct; 44(4):311-5. PubMed ID: 11592866 [TBL] [Abstract][Full Text] [Related]
4. Different response of the rat left and right heart to norepinephrine. Irlbeck M; Muhling O; Iwai T; Zimmer HG Cardiovasc Res; 1996 Jan; 31(1):157-62. PubMed ID: 8849601 [TBL] [Abstract][Full Text] [Related]
5. Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril. van Veldhuisen DJ; Brodde OE; van Gilst WH; Schulze C; Hegeman H; Anthonio RL; Scholtens E; de Graeff PA; Wesseling H; Lie KI Cardiovasc Res; 1995 Sep; 30(3):386-93. PubMed ID: 7585830 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction. Marie C; Mossiat C; Lecomte JM; Schwartz JC; Bralet J J Pharmacol Exp Ther; 1995 Dec; 275(3):1324-31. PubMed ID: 8531099 [TBL] [Abstract][Full Text] [Related]
7. I(f) current mediates beta-adrenergic enhancement of heart rate but not contractility in vivo. Guth BD; Dietze T Basic Res Cardiol; 1995; 90(3):192-202. PubMed ID: 7575372 [TBL] [Abstract][Full Text] [Related]
8. Effects of chronic norepinephrine administration on cardiac function in rats. Laycock SK; McMurray J; Kane KA; Parratt JR J Cardiovasc Pharmacol; 1995 Oct; 26(4):584-9. PubMed ID: 8569219 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of captopril and enalapril in obese Zucker rats. Duarte J; Martinez A; Bermejo A; Vera B; Gámez MJ; Cabo P; Zarzuelo A Eur J Pharmacol; 1999 Jan; 365(2-3):225-32. PubMed ID: 9988106 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition. Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784 [TBL] [Abstract][Full Text] [Related]
11. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats. Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682 [TBL] [Abstract][Full Text] [Related]
12. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril. Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346 [TBL] [Abstract][Full Text] [Related]
13. Cardiac responses after norepinephrine-induced ventricular hypertrophy in rats. Brown L; Sernia C; Newling R; Fletcher P J Cardiovasc Pharmacol; 1992 Aug; 20(2):316-23. PubMed ID: 1381025 [TBL] [Abstract][Full Text] [Related]
14. Converting enzyme inhibition with captopril abolishes sympathoexcitation to euglycemic hyperinsulinemia in rats. Muntzel MS; Morales J; Akinsefunmi A Am J Hypertens; 2001 Jun; 14(6 Pt 1):592-8. PubMed ID: 11411741 [TBL] [Abstract][Full Text] [Related]
15. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade. Bedotto JB; Gay RG; Graham SD; Morkin E; Goldman S J Pharmacol Exp Ther; 1989 Feb; 248(2):632-6. PubMed ID: 2537405 [TBL] [Abstract][Full Text] [Related]
16. Modulation of adrenergic receptors during left ventricular hypertrophy development and after regression by captopril. Martínez ML; Fernández-Tomé P; López-Miranda V; Colado MI; Delgado C J Cardiovasc Pharmacol; 1999 Oct; 34(4):505-11. PubMed ID: 10511124 [TBL] [Abstract][Full Text] [Related]
17. Comparative cardiovascular effects of a novel angiotensin converting enzyme inhibitor altiopril calcium (MC-838) and captopril in spontaneously hypertensive rats. Akima M; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1988; 292():223-36. PubMed ID: 3293543 [TBL] [Abstract][Full Text] [Related]
18. Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expression. Blais C; Lapointe N; Rouleau JL; Clément R; Bachvarov DR; Adam A Can J Physiol Pharmacol; 2002 Jan; 80(1):48-58. PubMed ID: 11911226 [TBL] [Abstract][Full Text] [Related]
19. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats. Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380 [TBL] [Abstract][Full Text] [Related]
20. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats. Ninahuaman MF; Souccar C; Lapa AJ; Lima-Landman MT Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]